KINETIC-ANALYSIS OF K+ ION CHANNEL FUNCTION IN LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS

被引:2
|
作者
LEFEVER, A [1 ]
LIEPINS, A [1 ]
机构
[1] MEM UNIV NEWFOUNDLAND, FAC MED, St John A1B 3V6, NEWFOUNDLAND, CANADA
关键词
D O I
10.3109/08923979009006459
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
K+ ion channels of lymphocytes have been implicated in cellular differentiation, activation and cytolytic functions. We previously demonstrated that K+ channel blockers modulate lytic activity of CTLs and LAK cells. In the present study, we define and quantitate the inhibitory effects of ion channel blockers on the lytic process using kinetic analysis of lysis. The K+ channel blocker, 4-aminopyridine, the neuroendocrine monoamine, serotonin, its agonist, quipazine, and the Ca+plus; dependent K+ channel blocker, quinidine were found to non-competitively inhibit the lytic process in a dose-dependent manner. These compounds inhibit lytic activity by causing a decrease in the maximum velocity (Vmax) by which LAK cells lyse tumor targets. These ion channel blockers did not alter effector or target cell viability or the binding of LAK cells to tumor cells. The inhibitory effects occurred at the effector cell level, since pre incubation of LAK effector cells resulted in a dose-dependent decrease in Vmax which was related to a slower rate of target cell lytic programming (k2) by the LAK effector cells. Modulation of LAK cell lytic function occurs at a post-binding step, perhaps in the generation or release of the lytic signal. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:23 / 38
页数:16
相关论文
共 50 条
  • [31] GENERATION OF LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FROM TUMOR-INFILTRATING LYMPHOCYTES
    NISHIMURA, T
    YAGI, H
    UCHIYAMA, Y
    HASHIMOTO, Y
    [J]. CELLULAR IMMUNOLOGY, 1986, 100 (01) : 149 - 157
  • [32] GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELLS (LAK) BY NORMAL HOSTS AND BY TUMOR BEARERS
    HARGROVE, ME
    YUN, YS
    TING, CC
    [J]. FEDERATION PROCEEDINGS, 1987, 46 (04) : 1509 - 1509
  • [33] THE GENERATION OF HUMAN LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS USING INTERLEUKIN-4
    JADUS, MR
    GOOD, RW
    CRUMPACKER, DB
    YANNELLI, JR
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (03): : 329 - 329
  • [34] CHARACTERIZATION OF LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FROM HUMAN INTESTINAL-MUCOSA
    HOGAN, PG
    HAPEL, AJ
    DOE, WF
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1986, 16 (01): : 168 - 168
  • [35] INHIBITION OF MURINE LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY BY ADHERENT CELLS
    LONGLEY, RE
    STEWART, D
    ROE, KG
    GOOD, RA
    [J]. CELLULAR IMMUNOLOGY, 1989, 121 (02) : 225 - 236
  • [36] HUMAN LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS - IDENTIFICATION OF 2 TYPES OF EFFECTOR-CELLS
    TILDEN, AB
    ITOH, K
    BALCH, CM
    [J]. JOURNAL OF IMMUNOLOGY, 1987, 138 (04): : 1068 - 1073
  • [37] SOLUBLE GLUCAN AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS IN THE THERAPY OF EXPERIMENTAL HEPATIC METASTASES
    SHERWOOD, ER
    WILLIAMS, DL
    MCNAMEE, RB
    JONES, EL
    BROWDER, IW
    DILUZIO, NR
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1988, 7 (02): : 185 - 198
  • [38] THE DIFFERENTIAL SENSITIVITY OF SPONTANEOUS (NK) AND LYMPHOKINE-ACTIVATED (LAK) KILLER CELLS TO IMMUNOREGULATORY FACTORS
    IMIR, T
    SIBBITT, W
    BANKHURST, A
    [J]. FEDERATION PROCEEDINGS, 1985, 44 (03) : 590 - 590
  • [39] A FUNCTIONAL AND PHENOTYPIC COMPARISON OF MURINE NATURAL-KILLER (NK) CELLS AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    HOSKIN, DW
    STANKOVA, J
    ANDERSON, SK
    RODER, JC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (05) : 940 - 948
  • [40] LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS ARE IDENTICAL TO THE UTERINE GRANULATED METRIAL GLAND (GMG) CELLS
    GINSBURG, H
    COLEMAN, R
    DAVIDSON, S
    KHOURY, C
    MOR, R
    [J]. TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 186 - 189